US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist

0.091
-0.013-12.50%

Close Nov 25 16:00 ET

0.090
-0.001-1.21%

Post 18:11 ET

9.36MMarket Cap-433P/E (TTM)

Conduit Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-281.49%-2M

-252.68%-1.51M

-19.71%-2.36M

-240.91%-7.73M

-445.80%-4.8M

-524K

-429K

-149.87%-1.97M

-5.35%-2.27M

-880K

Net income from continuing operations

-346.13%-6.46M

-210.62%-5.38M

-112.44%-3.55M

89.05%-535K

107.98%245K

--2.63M

---1.73M

-444.63%-1.67M

-33.63%-4.89M

---3.07M

Operating gains losses

98.43%-51K

183.65%2.12M

459.56%489K

-493.63%-5.63M

-339.21%-2.98M

---3.25M

--746K

-950.00%-136K

859.06%1.43M

--1.25M

Other non cash items

969.16%2.29M

949.21%661K

67.61%476K

274.34%992K

268.38%431K

--214K

--63K

--284K

--265K

--117K

Change In working capital

313.30%1.86M

49.88%610K

70.83%-201K

-522.15%-2.52M

-641.33%-2.69M

--451K

--407K

-38.63%-689K

-56.08%596K

--496K

-Change in prepaid assets

117.58%96K

61.94%-153K

68.97%-153K

---990K

--451K

---546K

---402K

---493K

--0

-Change in payables and accrued expense

77.33%1.77M

-5.69%763K

75.51%-48K

-354.74%-1.53M

-733.27%-3.14M

--997K

--809K

60.56%-196K

-55.71%601K

--496K

-Change in other current assets

----

200.00%5K

----

---5K

--0

Cash from discontinued investing activities

Operating cash flow

-281.49%-2M

-253.50%-1.51M

-19.64%-2.36M

-240.91%-7.73M

-445.80%-4.8M

---524K

---428K

-150.00%-1.97M

-5.35%-2.27M

---880K

Investing cash flow

Cash flow from continuing investing activities

43.28%96K

-155.45%-224K

496.17%725K

1,020.37%497K

67K

404K

-243K

-183K

-54K

Net PPE purchase and sale

---41K

----

--0

----

Net investment purchase and sale

48.91%137K

----

235.81%497K

---88K

--92K

----

--148K

----

Net other investing changes

----

168.88%228K

389.60%585K

---25K

---89K

---243K

---331K

---202K

Cash from discontinued investing activities

Investing cash flow

43.28%96K

-155.45%-224K

--0

496.17%725K

1,020.37%497K

--67K

--404K

---243K

---183K

---54K

Financing cash flow

Cash flow from continuing financing activities

-80.86%1.74M

927.27%113K

346.45%10.93M

-144.37%-414K

9.11M

11K

181.37%2.22M

28.98%2.45M

933K

Net issuance payments of debt

218.07%1.74M

--0

106.50%2.29M

-216.82%-493K

--548K

--11K

--2.22M

60.90%1.11M

--422K

Net common stock issuance

----

--0

----

10.83%1.34M

--511K

Proceeds from stock option exercised by employees

--1K

----

--0

----

Net other financing activities

----

--8.64M

---2K

----

Cash from discontinued financing activities

Financing cash flow

-80.86%1.74M

927.27%113K

--0

346.45%10.93M

-144.37%-414K

--9.11M

--11K

181.37%2.22M

28.98%2.45M

--933K

Net cash flow

Beginning cash position

--219K

22,950.00%1.84M

--4.23M

--0

--8.64M

--0

--8K

--0

Current changes in cash

-101.84%-159K

-12,392.31%-1.62M

-33,771.43%-2.36M

393,000.00%3.93M

---4.72M

--8.66M

---13K

600.00%7K

99.60%-1K

----

Effect of exchange rate changes

200.00%11K

-120.00%-1K

-2,800.00%-27K

29,800.00%299K

30,300.00%304K

---11K

--5K

0.00%1K

--1K

End cash Position

-99.18%71K

--219K

22,950.00%1.84M

--4.23M

--8.64M

--0

300.00%8K

--0

Free cash flow

-289.31%-2.04M

-255.84%-1.52M

-19.64%-2.36M

-240.91%-7.73M

-445.80%-4.8M

---524K

---428K

-150.00%-1.97M

-5.35%-2.27M

---880K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-281.49%-2M	-252.68%-1.51M	-19.71%-2.36M	-240.91%-7.73M	-445.80%-4.8M	-524K	-429K	-149.87%-1.97M	-5.35%-2.27M	-880K
Net income from continuing operations	-346.13%-6.46M	-210.62%-5.38M	-112.44%-3.55M	89.05%-535K	107.98%245K	--2.63M	---1.73M	-444.63%-1.67M	-33.63%-4.89M	---3.07M
Operating gains losses	98.43%-51K	183.65%2.12M	459.56%489K	-493.63%-5.63M	-339.21%-2.98M	---3.25M	--746K	-950.00%-136K	859.06%1.43M	--1.25M
Other non cash items	969.16%2.29M	949.21%661K	67.61%476K	274.34%992K	268.38%431K	--214K	--63K	--284K	--265K	--117K
Change In working capital	313.30%1.86M	49.88%610K	70.83%-201K	-522.15%-2.52M	-641.33%-2.69M	--451K	--407K	-38.63%-689K	-56.08%596K	--496K
-Change in prepaid assets	117.58%96K	61.94%-153K	68.97%-153K	---990K	--451K	---546K	---402K	---493K	--0	--0
-Change in payables and accrued expense	77.33%1.77M	-5.69%763K	75.51%-48K	-354.74%-1.53M	-733.27%-3.14M	--997K	--809K	60.56%-196K	-55.71%601K	--496K
-Change in other current assets	----	----	----	200.00%5K	----	----	----	----	---5K	--0
Cash from discontinued investing activities
Operating cash flow	-281.49%-2M	-253.50%-1.51M	-19.64%-2.36M	-240.91%-7.73M	-445.80%-4.8M	---524K	---428K	-150.00%-1.97M	-5.35%-2.27M	---880K
Investing cash flow
Cash flow from continuing investing activities	43.28%96K	-155.45%-224K	0	496.17%725K	1,020.37%497K	67K	404K	-243K	-183K	-54K
Net PPE purchase and sale	---41K	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	48.91%137K	----	----	235.81%497K	---88K	--92K	----	----	--148K	----
Net other investing changes	----	----	----	168.88%228K	389.60%585K	---25K	---89K	---243K	---331K	---202K
Cash from discontinued investing activities
Investing cash flow	43.28%96K	-155.45%-224K	--0	496.17%725K	1,020.37%497K	--67K	--404K	---243K	---183K	---54K
Financing cash flow
Cash flow from continuing financing activities	-80.86%1.74M	927.27%113K	0	346.45%10.93M	-144.37%-414K	9.11M	11K	181.37%2.22M	28.98%2.45M	933K
Net issuance payments of debt	218.07%1.74M	--0	--0	106.50%2.29M	-216.82%-493K	--548K	--11K	--2.22M	60.90%1.11M	--422K
Net common stock issuance	----	----	----	--0	----	----	----	----	10.83%1.34M	--511K
Proceeds from stock option exercised by employees	--1K	----	----	----	----	--0	----	----	----	----
Net other financing activities	----	----	----	--8.64M	---2K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-80.86%1.74M	927.27%113K	--0	346.45%10.93M	-144.37%-414K	--9.11M	--11K	181.37%2.22M	28.98%2.45M	--933K
Net cash flow
Beginning cash position	--219K	22,950.00%1.84M	--4.23M	--0	--8.64M	--0	--8K	--0	--0	--0
Current changes in cash	-101.84%-159K	-12,392.31%-1.62M	-33,771.43%-2.36M	393,000.00%3.93M	---4.72M	--8.66M	---13K	600.00%7K	99.60%-1K	----
Effect of exchange rate changes	200.00%11K	-120.00%-1K	-2,800.00%-27K	29,800.00%299K	30,300.00%304K	---11K	--5K	0.00%1K	0.00%1K	--1K
End cash Position	-99.18%71K	--219K	22,950.00%1.84M	--4.23M	--4.23M	--8.64M	--0	300.00%8K	--0	--0
Free cash flow	-289.31%-2.04M	-255.84%-1.52M	-19.64%-2.36M	-240.91%-7.73M	-445.80%-4.8M	---524K	---428K	-150.00%-1.97M	-5.35%-2.27M	---880K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data